Showing results (821-830 of 843) with videos related to
Sort By:
Pageof 85
Plos Pathogens|August 4, 2015
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesSampa Santra, Georgia D Tomaras, Ranjit Warrier, et al.Science Translational Medicine|March 17, 2017
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodiesMattia Bonsignori, Edward F Kreider, Daniela Fera, et al.Cell|May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.Nature|November 25, 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Jason S McLellan, Marie Pancera, Chris Carrico, et al.Science (New York, N.Y.)|August 1, 2015
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodiesWilton B Williams, Hua-Xin Liao, M Anthony Moody, et al.JCI Insight|December 13, 2016
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaquesKan Luo, Hua-Xin Liao, Ruijun Zhang, et al.Nature|May 10, 2021
Neutralizing antibody vaccine for pandemic and pre-emergent coronavirusesKevin O Saunders, Esther Lee, Robert Parks, et al.Cell|March 8, 2016
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyMattia Bonsignori, Tongqing Zhou, Zizhang Sheng, et al.Science Immunology|February 13, 2026
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody developmentRumi Habib, Ryan S Roark, Hui Li, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody developmentRumi Habib, Ryan S Roark, Hui Li, et al.Pageof 85